Emergency Contraption Pill Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

Ohm is the best-performing emergency contraption pill brand in July 2026, moving 11,000 units across 2 ASINs for 52.1% of Top 10 volume. Glenmark Therapeutics follows with 5,000 units (23.7%), ahead of Xiromed on 2,000 units (9.5%).

With 6 brands splitting the Top 10 and 85.3% of volume sitting with three of them, this is a concentrated shelf — the leaders hold multiple listings or one very high-velocity ASIN, so a new entrant competes against established review moats rather than an open field. Average selling prices among the leaders run from $6.38 to $18.73, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. On the growth side, B09MKYGFW9 leads positive momentum with ▲ 66.7% MoM growth on 1K units, with B0D6ZV1SLR close behind at ▲ 50.0% MoM on 300 units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.